Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) National Immunisation Programme (21)
  • (-) WHO Collaborating Centre for Tobacco Product Regulation and Control (11)
  • (-) Population screening programmes (5)
  • (-) Dutch Food Composition Database (NEVO) (2)
  • International (250)
  • COVID-19 vaccination (159)
  • COVID-19 (147)
  • Antimicrobial resistance (19)
  • Immunisation and vaccination (17)
  • Circular economy (16)
  • Tobacco (16)
  • Air (14)
  • COVID-19 (14)
  • Zoonotic diseases (14)
  • Heat (13)
  • HPV vaccination (13)
  • Flu and flu vaccine (11)
  • Healthy living environment (11)
  • Nanotechnology (11)
  • One Health (11)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (11)
  • Ebola (10)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (10)
  • Food safety (9)
  • Medical devices (9)
  • Plastics (9)
  • Nitrogen (8)
  • Health research for COVID-19 (7)
  • Measles (7)
  • Mpox (7)
  • PFAS (7)
  • Sexually transmitted infections (STIs) (7)
  • Soil and water (7)
  • Sustainable Development Goals (7)
  • Tuberculosis (7)
  • WHO Collaborating Centre on Chemical Food Safety (7)
  • Food and Nutrition (6)
  • Public Health Foresight (6)
  • Salmonella (6)
  • Sustainability (6)
  • MERS-coronavirus (5)
  • Tick-borne encephalitis (5)
  • WHO Collaborating Centre for Nutrition (5)
  • Accidents and disasters (4)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Dutch National Food Consumption Survey (4)
  • Food Reformulation (4)
  • Hydrofluorocarbons (4)
  • Occupational Safety (4)
  • Rubber granulate (4)
  • Chromium (VI) and CARC (3)
  • Climate change and Health (3)
  • ConsExpo (3)
  • Heel prick (3)
  • Legionnaires' disease (Legionellosis) (3)
  • Meningococcal ACWY (3)
  • Mosquitos (3)
  • Pharmaceuticals in the environment (3)
  • Physical Activity (3)
  • Replacement, reduction, refinement of animal use (3Rs) (3)
  • RSV (3)
  • West Nile fever (3)
  • Assistance RIVM Sint Maarten landfill (2)
  • CAESAR (2)
  • Cervical cancer screening programme (2)
  • Consumer exposure to chemical substances (2)
  • International projects (2)
  • Population screening programmes in the Caribbean Netherlands (2)
  • UV ozone layer and climate (2)
  • Beeldschermgebruik (1)
  • Breast Cancer Screening Programme (1)
  • Chikungunya (1)
  • Chikungunya (1)
  • Chroom-6 (1)
  • Dengue (1)
  • E-health (digitale zorg) (1)
  • GenX (1)
  • Health promotion (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Perinatal screening (1)
  • PFAS (1)
  • PFOA (1)
  • Pneumococci (1)
  • Polio (1)
  • Radiation exposure in the Netherlands (1)
  • Rotavirus (1)
  • Sewage research (1)
  • Sustainable procurement (1)
  • Synthetic biology (1)
  • Veilige leefomgeving (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)
  • WHO Collaborating Centre on Life Course and Health (1)
  • Zika Virus (1)

Publication date

  • February 2023 (1)
  • November 2022 (1)
  • October 2022 (2)
  • July 2022 (2)
  • May 2022 (2)
  • February 2022 (1)
  • January 2022 (1)
  • December 2021 (1)
  • May 2021 (1)
  • November 2020 (1)
  • June 2020 (2)
  • March 2020 (1)
  • January 2020 (1)
  • December 2019 (2)
  • November 2019 (1)
  • September 2019 (1)
  • May 2019 (1)
  • April 2019 (1)
  • March 2019 (1)
  • December 2018 (1)
  • September 2018 (2)
  • June 2018 (2)
  • May 2018 (2)
  • September 2016 (1)
  • March 2016 (1)
  • April 2015 (3)
  • March 2015 (1)
  • April 2014 (1)
  • December 2013 (1)

Provisional figures on participation in the National Immunisation Programme

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).

02/02/2023 - 11:00
baby en peuter

National Immunisation Programme: new decline in number of reported cases of disease in 2021

In 2021, fewer people contracted diseases for which vaccines are offered under the National Immunisation Programme (NIP) than before the coronavirus pandemic. This is very likely largely due to the impact of the coronavirus measures, such as social distancing and hand washing.
11/17/2022 - 13:45

Patient with cutaneous diphtheria in reception centre

This week, a refugee from Syria was found to be infected with the diphtheria bacterium. The patient has been treated with antibiotics. The patient’s contacts have been tested and vaccinated.

10/21/2022 - 11:48
Verbonden arm

Cancer screening programmes now more accessible to transgender and intersex persons

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.

10/11/2022 - 17:22
Transgender symbool

Side effect reports National Immunisation Programme 2021

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
07/25/2022 - 17:10
Meisje vier jaar

Participation in National Immunisation Programme shows slight decrease

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.

07/04/2022 - 12:30
Rijksvaccinatie voorkant rapport

From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.

05/20/2022 - 11:39

Tailor-made information will help immigrants make decisions on taking part in screening programmes

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.

05/13/2022 - 10:03
Vier vrouwen op een pleintje

Impact of coronavirus outbreak on participation in National Immunisation Programme limited

Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).

02/22/2022 - 10:45
Vader en moeder spelen met jonge kinderen met speelgoed

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
01/31/2022 - 14:58
Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • › Next ›
  • » Last »

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Volg ons

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram